The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis

Stephen Weis, Philip C. Slocum, Francis X. Blais, Barbara King, Mary Nunn, G. Burgis Matney, Enriqueta Gomez, Brian H. Foresman

Research output: Contribution to journalArticle

519 Citations (Scopus)

Abstract

Tuberculosis has reemerged as an important public health problem, and the frequency of drug resistance is increasing. A major reason for the development of resistant infections and relapse is poor compliance with medical regimens. In Tarrant County, Texas, we initiated a program of universal directly observed treatment for tuberculosis. We report the effect of the program on the rates of primary and acquired drug resistance and relapse among patients with tuberculosis. We collected information on all patients with positive cultures for Mycobacterium tuberculosis in Tarrant County from January 1, 1980, through December 31, 1992. Through October 1986, patients received a traditional, unsupervised drug regimen. Beginning in November 1986, nearly all patients received therapy under direct observation by health care personnel. A total of 407 episodes in which patients received traditional treatment for tuberculosis (January 1980 through October 1986) were compared with 581 episodes in which therapy was directly observed (November 1986 through December 1992). Despite higher rates of intravenous drug use and homelessness and an increasing rate of tuberculosis during this 13-year period, the frequency of primary drug resistance decreased from 13.0 percent to 6.7 percent (P<0.001) after the institution of direct observation of therapy, and the frequency of acquired resistance declined from 14.0 percent to 2.1 percent (P<0.001). The relapse rate decreased from 20.9 percent to 5.5 percent (P<0.001), and the number of relapses with multidrug-resistant organisms decreased from 25 to 5 (P<0.001). The administration of therapy for M. tuberculosis infection under direct observation leads to significant reductions in the frequency of primary drug resistance, acquired drug resistance, and relapse.

Original languageEnglish
Pages (from-to)1179-1184
Number of pages6
JournalNew England Journal of Medicine
Volume330
Issue number17
DOIs
StatePublished - 28 Apr 1994

Fingerprint

Directly Observed Therapy
Drug Resistance
Tuberculosis
Recurrence
Observation
Mycobacterium tuberculosis
Therapeutics
Homeless Persons
Mycobacterium Infections
Pharmaceutical Preparations
Health Personnel
Public Health
Delivery of Health Care
Infection

Cite this

Weis, Stephen ; Slocum, Philip C. ; Blais, Francis X. ; King, Barbara ; Nunn, Mary ; Matney, G. Burgis ; Gomez, Enriqueta ; Foresman, Brian H. / The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. In: New England Journal of Medicine. 1994 ; Vol. 330, No. 17. pp. 1179-1184.
@article{d67bae9860074b38a1003154e535f22c,
title = "The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis",
abstract = "Tuberculosis has reemerged as an important public health problem, and the frequency of drug resistance is increasing. A major reason for the development of resistant infections and relapse is poor compliance with medical regimens. In Tarrant County, Texas, we initiated a program of universal directly observed treatment for tuberculosis. We report the effect of the program on the rates of primary and acquired drug resistance and relapse among patients with tuberculosis. We collected information on all patients with positive cultures for Mycobacterium tuberculosis in Tarrant County from January 1, 1980, through December 31, 1992. Through October 1986, patients received a traditional, unsupervised drug regimen. Beginning in November 1986, nearly all patients received therapy under direct observation by health care personnel. A total of 407 episodes in which patients received traditional treatment for tuberculosis (January 1980 through October 1986) were compared with 581 episodes in which therapy was directly observed (November 1986 through December 1992). Despite higher rates of intravenous drug use and homelessness and an increasing rate of tuberculosis during this 13-year period, the frequency of primary drug resistance decreased from 13.0 percent to 6.7 percent (P<0.001) after the institution of direct observation of therapy, and the frequency of acquired resistance declined from 14.0 percent to 2.1 percent (P<0.001). The relapse rate decreased from 20.9 percent to 5.5 percent (P<0.001), and the number of relapses with multidrug-resistant organisms decreased from 25 to 5 (P<0.001). The administration of therapy for M. tuberculosis infection under direct observation leads to significant reductions in the frequency of primary drug resistance, acquired drug resistance, and relapse.",
author = "Stephen Weis and Slocum, {Philip C.} and Blais, {Francis X.} and Barbara King and Mary Nunn and Matney, {G. Burgis} and Enriqueta Gomez and Foresman, {Brian H.}",
year = "1994",
month = "4",
day = "28",
doi = "10.1056/NEJM199404283301702",
language = "English",
volume = "330",
pages = "1179--1184",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "17",

}

Weis, S, Slocum, PC, Blais, FX, King, B, Nunn, M, Matney, GB, Gomez, E & Foresman, BH 1994, 'The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis', New England Journal of Medicine, vol. 330, no. 17, pp. 1179-1184. https://doi.org/10.1056/NEJM199404283301702

The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. / Weis, Stephen; Slocum, Philip C.; Blais, Francis X.; King, Barbara; Nunn, Mary; Matney, G. Burgis; Gomez, Enriqueta; Foresman, Brian H.

In: New England Journal of Medicine, Vol. 330, No. 17, 28.04.1994, p. 1179-1184.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis

AU - Weis, Stephen

AU - Slocum, Philip C.

AU - Blais, Francis X.

AU - King, Barbara

AU - Nunn, Mary

AU - Matney, G. Burgis

AU - Gomez, Enriqueta

AU - Foresman, Brian H.

PY - 1994/4/28

Y1 - 1994/4/28

N2 - Tuberculosis has reemerged as an important public health problem, and the frequency of drug resistance is increasing. A major reason for the development of resistant infections and relapse is poor compliance with medical regimens. In Tarrant County, Texas, we initiated a program of universal directly observed treatment for tuberculosis. We report the effect of the program on the rates of primary and acquired drug resistance and relapse among patients with tuberculosis. We collected information on all patients with positive cultures for Mycobacterium tuberculosis in Tarrant County from January 1, 1980, through December 31, 1992. Through October 1986, patients received a traditional, unsupervised drug regimen. Beginning in November 1986, nearly all patients received therapy under direct observation by health care personnel. A total of 407 episodes in which patients received traditional treatment for tuberculosis (January 1980 through October 1986) were compared with 581 episodes in which therapy was directly observed (November 1986 through December 1992). Despite higher rates of intravenous drug use and homelessness and an increasing rate of tuberculosis during this 13-year period, the frequency of primary drug resistance decreased from 13.0 percent to 6.7 percent (P<0.001) after the institution of direct observation of therapy, and the frequency of acquired resistance declined from 14.0 percent to 2.1 percent (P<0.001). The relapse rate decreased from 20.9 percent to 5.5 percent (P<0.001), and the number of relapses with multidrug-resistant organisms decreased from 25 to 5 (P<0.001). The administration of therapy for M. tuberculosis infection under direct observation leads to significant reductions in the frequency of primary drug resistance, acquired drug resistance, and relapse.

AB - Tuberculosis has reemerged as an important public health problem, and the frequency of drug resistance is increasing. A major reason for the development of resistant infections and relapse is poor compliance with medical regimens. In Tarrant County, Texas, we initiated a program of universal directly observed treatment for tuberculosis. We report the effect of the program on the rates of primary and acquired drug resistance and relapse among patients with tuberculosis. We collected information on all patients with positive cultures for Mycobacterium tuberculosis in Tarrant County from January 1, 1980, through December 31, 1992. Through October 1986, patients received a traditional, unsupervised drug regimen. Beginning in November 1986, nearly all patients received therapy under direct observation by health care personnel. A total of 407 episodes in which patients received traditional treatment for tuberculosis (January 1980 through October 1986) were compared with 581 episodes in which therapy was directly observed (November 1986 through December 1992). Despite higher rates of intravenous drug use and homelessness and an increasing rate of tuberculosis during this 13-year period, the frequency of primary drug resistance decreased from 13.0 percent to 6.7 percent (P<0.001) after the institution of direct observation of therapy, and the frequency of acquired resistance declined from 14.0 percent to 2.1 percent (P<0.001). The relapse rate decreased from 20.9 percent to 5.5 percent (P<0.001), and the number of relapses with multidrug-resistant organisms decreased from 25 to 5 (P<0.001). The administration of therapy for M. tuberculosis infection under direct observation leads to significant reductions in the frequency of primary drug resistance, acquired drug resistance, and relapse.

UR - http://www.scopus.com/inward/record.url?scp=0028274105&partnerID=8YFLogxK

U2 - 10.1056/NEJM199404283301702

DO - 10.1056/NEJM199404283301702

M3 - Article

C2 - 8139628

AN - SCOPUS:0028274105

VL - 330

SP - 1179

EP - 1184

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 17

ER -